剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

未开盘 10-16 16:08:16

11.920

+0.740

+6.62%

最高12.190	最低11.460	成交量869.55万
今开11.500	昨收11.180	日振幅6.53%
总市值141.01亿	流通市值129.09亿	总股本11.83亿
成交额1.03亿	换手率0.80%	流通股本10.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":11.92,"timestamp":1792138096008,"preClose":11.18,"halted":0,"volume":8695500,"delay":0,"changeRate":0.06618962432915923,"floatShares":1083000000,"shares":1183000000,"eps":-0.5470462336164,"marketStatus":"未开盘","change":0.74,"latestTime":"10-16 16:08:16","open":11.5,"high":12.19,"low":11.46,"amount":102769405,"amplitude":0.065295,"askPrice":11.92,"askSize":1500,"bidPrice":11.91,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.40402059428320275,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":11.18,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":0.8003764710182225,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"2676500681","title":"剂泰科技-P(07666.HK)：与礼来达成战略合作以推进新一代组织特异性LNP递送技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2676500681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676500681?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:48","pubTimestamp":1792406891,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","HK0000165453.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127188768","title":"剂泰科技-P（07666）宣布与礼来达成新一代组织特异性LNP递送技术战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1127188768","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127188768?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:21","pubTimestamp":1792405276,"startTime":"0","endTime":"0","summary":"2026年10月19日，剂泰科技（北京）股份有限公司公布，其已与Eli Lilly and Company（礼来）签署战略合作协议，双方将共同开发新型脂质纳米粒递送解决方案，目标是实现治疗方式的组织特异性递送。双方合作旨在发现并优化具有更高组织特异性的LNP架构，拓展其在多疾病领域的应用。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675455420","title":"港股异动 | 剂泰科技-P(07666.HK)早盘涨近8% 医药十五五规划提出打造AI制药高价值应用场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2675455420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675455420?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:41","pubTimestamp":1792114901,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01477","09939","HK0000165453.HKD","BK1161","BK1574","BK1191","BK1515","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107764485","title":"异动解读｜剂泰科技-P盘中上涨7.6%，AI制药板块回暖带动反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1107764485","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107764485?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:34","pubTimestamp":1792114487,"startTime":"0","endTime":"0","summary":"10月16日，剂泰科技-P盘中上涨7.6%，报11.74港元，成交额978.26万港元。消息面上，港股生物科技板块走强，AI制药相关个股情绪回暖，带动公司股价反弹。公司此前披露中期业绩显示，上半年营收1.54亿元，同比大增13399%，经调整净亏损收窄56.4%至0.51亿元；同时公司已于9月获纳入港股通，叠加NanoForge商业化成果释放，基本面改善为股价提供支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技异动拉升，AI制药板块回暖","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105266929","title":"异动解读｜剂泰科技-P盘中下跌5.6%，生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1105266929","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105266929?lang=zh_cn&edition=full","pubTime":"2026-10-14 11:37","pubTimestamp":1791949048,"startTime":"0","endTime":"0","summary":"10月14日，剂泰科技-P盘中下跌5.6%，报11.12港元，成交额3514.03万港元。消息面上，港股生物科技板块延续弱势，AI制药概念相关个股普遍承压，板块系统性回调仍是股价波动的主因。此前公司中期业绩显示，上半年营收1.54亿元，同比大增13399%，经调整净亏损收窄56.4%至0.51亿元，基本面虽有改善，但近期美国利率预期变化对高久期、零收入型生物科技公司形成持续压制。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"剂泰科技盘中下行，生物科技板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157597540","title":"异动解读｜剂泰科技-P盘中下跌6.34%，生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1157597540","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157597540?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:35","pubTimestamp":1791855302,"startTime":"0","endTime":"0","summary":"10月13日，剂泰科技-P盘中下跌6.34%，报12.13港元，成交额1700.79万港元。消息面上，港股生物科技板块延续弱势，AI制药概念相关个股普遍承压。美国利率预期变化对高久期、零收入型生物科技公司形成持续压制，前期大幅走高的板块遭遇系统性回调。公司中期业绩显示营收1.54亿元，同比大增13399%，经调整净亏损收窄56.4%至0.51亿元，基本面虽持续改善，但短期板块系统性回调主导了股价表现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"剂泰科技盘中下挫，生物科技板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163657401","title":"异动解读｜剂泰科技-P盘中下跌5.01%，生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1163657401","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163657401?lang=zh_cn&edition=full","pubTime":"2026-10-12 13:31","pubTimestamp":1791783094,"startTime":"0","endTime":"0","summary":"10月12日，剂泰科技-P盘中下跌5.01%，报13.84港元，成交额5564.31万港元。消息面上，生物科技板块整体情绪偏弱，港股生物医药股在前期大幅走高后遭遇回调，AI制药概念相关个股普遍承压。近期美国利率预期变化对高久期、零收入型生物科技公司形成持续压制，板块内多只个股走低。公司中期业绩显示营收1.54亿元，同比大增13399%，经调整净亏损收窄56.4%至0.51亿元，基本面虽持续改善，但短期板块系统性回调主导了股价表现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"生物科技板块承压，剂泰科技盘中下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198677384","title":"一周港股牛熊榜 | 利好消息推动两股周内飙逾27%！白鸽在线推进H股全流通，本末科技牵手稀土巨头；金界控股遭美银降级，周跌18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198677384","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198677384?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:59","pubTimestamp":1791593943,"startTime":"0","endTime":"0","summary":"总结全周，港股个股表现分化，华夏文化科技本周累升39.00%领涨；中环新能源累计下跌22.83%，为榜单中表现最弱个股。相关方案仍须经股东大会批准，并取得中国证监会备案及联交所批准后方可实施。该行指出，金界控股博彩收入增长持续放缓，由第一季度同比增长2.1%，转为第二季度下跌20%、第三季度下跌43%，短期内博彩收入复苏的能见度有限。业务方面，中环新能源正推进新能源与AI算力业务协同发展。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01735","03918","02672","02142","01566","06731","02442","07666","02768","09900"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1189875161","title":"异动解读｜剂泰科技-P盘中下跌6.37%，生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1189875161","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189875161?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:05","pubTimestamp":1791511502,"startTime":"0","endTime":"0","summary":"10月9日，剂泰科技-P盘中下跌6.37%，报14.7港元，成交额2110.0万港元。生物科技板块整体表现偏弱，个股中，信达生物跌2.59%，康方生物跌1.14%，百济神州跌2.44%，三生制药涨0.07%，康希诺生物跌2.45%。近期生物科技板块情绪持续波动，美国利率预期变化对高久期、零收入型生物科技公司形成压制，港股生物医药板块在前期大幅走高后遭遇回调，AI制药概念相关个股普遍承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"剂泰科技盘中下跌，生物科技板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1128174335","title":"异动解读｜剂泰科技-P盘中下跌5.04%，生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1128174335","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128174335?lang=zh_cn&edition=full","pubTime":"2026-10-08 10:20","pubTimestamp":1791426055,"startTime":"0","endTime":"0","summary":"10月8日，剂泰科技-P盘中下跌5.04%，报16.03港元，成交额5208.2万港元。剂泰科技-P所在的生物科技行业中，整体表现偏弱，个股中，康方生物涨0.09%，百济神州涨0.18%，康希诺生物跌0.47%，三生制药跌0.25%，信达生物跌0.92%。剂泰科技（北京）股份有限公司是一家主要从事人工智能纳米材料创新的中国公司。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137700101","title":"异动解读｜剂泰科技-P盘中下跌5.08%，生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1137700101","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137700101?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:36","pubTimestamp":1791337017,"startTime":"0","endTime":"0","summary":"10月7日，剂泰科技-P盘中下跌5.08%，报16.8港元，成交额461.51万港元。剂泰科技-P所在的生物科技行业中，整体表现偏弱，个股中，康希诺生物跌6.9%，和铂医药-B跌6.67%，信达生物跌2.16%，百济神州跌1.99%，康方生物跌1.72%。剂泰科技（北京）股份有限公司是一家主要从事人工智能纳米材料创新的中国公司。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125084505","title":"剂泰科技-P更新9月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125084505","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125084505?lang=zh_cn&edition=full","pubTime":"2026-10-06 17:51","pubTimestamp":1791280283,"startTime":"0","endTime":"0","summary":"剂泰科技(北京)股份有限公司-P于2026年10月6日发布了截至2026年9月30日的证券变动月报表。公告显示，报告期内公司注册股本及已发行股份情况保持稳定，未进行新增发行、回购或注销等活动，股本未发生变化。经公司确认，相关股份继续符合香港联合交易所有限公司主板上市规则对于公众持股量的规定。公司表示将持续合规披露公司股份变动情况，严格遵守香港联合交易所有限公司《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180272758","title":"异动解读｜剂泰科技-P盘中下跌5.32%，报17.04港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180272758","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180272758?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:50","pubTimestamp":1790905824,"startTime":"0","endTime":"0","summary":"10月2日，剂泰科技-P盘中下跌5.32%，报17.04港元/股，成交额901.16万港元。剂泰科技-P所在的生物科技行业整体承压，个股中，百济神州跌6.74%，三生制药跌5.91%，科伦博泰生物跌5.63%，信达生物跌4.84%，康方生物跌4.51%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122479318","title":"异动解读｜剂泰科技-P盘中上涨5.69%，中报业绩爆发叠加AI制药政策共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1122479318","media":"行情直击","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122479318?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:57","pubTimestamp":1790733437,"startTime":"0","endTime":"0","summary":"9月30日，剂泰科技-P盘中上涨5.69%，报16.88港元，成交额5219.07万港元。消息面上，公司近日披露中期业绩，上半年实现营收约1.54亿元，同比大增13,399%，超过去年全年收入47%；经调整净亏损收窄56.4%至约5,110万元。核心平台NanoForge商业化成果进入集中释放期，OpenCGT项目潜在交易总额已超60亿元。此外，公司9月初正式纳入港股通标的，南向资金通道打开；期间先后与绿叶制药、昭衍生物达成战略合作，AI制药亦被纳入医药工业五年计划重点任务，多重利好持续共振。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上扬，中报爆发叠加AI制药利好","news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671822138","title":"港股异动 | mRNA概念股涨幅居前 康希诺生物(06185)涨超17% 莫德纳mRNA新抗原疗法将亮相ESMO大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2671822138","media":"智通财经","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671822138?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:47","pubTimestamp":1790732842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，mRNA概念股涨幅居前，截至发稿，康希诺生物涨16.78%，报36.32港元；云顶新耀涨4.29%，报29.18港元；思路迪医药股份涨1.94%，报2.89港元；剂泰科技-P涨1.44%，报16.22港元。值得注意的是，8月25日，康希诺生物与德普世生物签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。此前在mRNA领域，康希诺生物已布局mRNA 疫苗用于胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发。云顶新耀计划在2026年第四季度开展对mRNA疫苗EVM16的 IIT Ib研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","06185","BK1574","BK1583","01952","KCAI","01244","BK4585","VXUS","BK4588","BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141526751","title":"剂泰科技-P2026年中期营收1.54亿元，经调整后净亏损0.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141526751","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141526751?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:23","pubTimestamp":1790673787,"startTime":"0","endTime":"0","summary":"根据公司最新披露的2026年中期报告，剂泰科技-P于报告期内实现来自客户合约的收入约1.54亿元，同比上年同期大幅增长13,399%。本期经调整后净亏损约0.51亿元，相比上年同期的1.17亿元收窄56.4%。报告期内经营活动产生的现金流出净额约1.62亿元，而上年同期为约0.96亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"剂泰科技-P2026年中期营收1.54亿元，经调整后净亏损0.51亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120179535","title":"异动解读｜剂泰科技-P盘中下跌6.21%，报16.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120179535","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120179535?lang=zh_cn&edition=full","pubTime":"2026-09-24 10:13","pubTimestamp":1790216028,"startTime":"0","endTime":"0","summary":"9月24日，剂泰科技-P盘中下跌6.21%，报16.3港元/股，成交额3716.49万港元。剂泰科技-P所在的生物科技行业中，个股普遍承压，康方生物跌3.69%，信达生物跌3.63%，百济神州跌1.47%，荣昌生物跌5.77%，三生制药跌3.76%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669743721","title":"港股异动 | 剂泰科技-P(07666)再涨超6% 跨赛道巨头布局AI4S制药 NanoForge商业化成果迎集中释放期","url":"https://stock-news.laohu8.com/highlight/detail?id=2669743721","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669743721?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:15","pubTimestamp":1790133344,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P再涨超6%，截至发稿，涨5.01%，报17.62港元，成交额7242.99万港元。东吴证券指出，全球科技巨头正在以不同路径深度嵌入生物医药，AI制药进入战略入局阶段。值得一提的是，上半年，剂泰科技NanoForge商业化成果进入集中释放期，期内营收超过1.54亿元，超过去年全年收入47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","07666","01477","BK1191","KCAI","BK1161","BK1574","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669174377","title":"港股异动 | 剂泰科技-P(07666.HK)再涨超6% 跨赛道巨头布局AI4S制药 NanoForge商业化成果迎集中释放期","url":"https://stock-news.laohu8.com/highlight/detail?id=2669174377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669174377?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:15","pubTimestamp":1790133344,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01477","07666","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125690103","title":"异动解读｜剂泰科技-P盘中上涨6.85%，CEO演讲强调Biological AI数据壁垒叠加十五五规划持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1125690103","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125690103?lang=zh_cn&edition=full","pubTime":"2026-09-23 10:43","pubTimestamp":1790131407,"startTime":"0","endTime":"0","summary":"9月23日，剂泰科技-P盘中上涨6.85%，报17.93港元，成交额5873.57万港元。消息面上，多重利好持续催化。公司联合创始人、CEO赖才达近日受邀发表主旨演讲，强调生物医药AI核心竞争力在于持续获取高质量实验数据并转化为模型能力，提出AI制药\"三层蛋糕\"技术架构。政策端，\"十五五\"规划将AI制药列入医药工业重点任务，明确培育高价值应用场景。业务端，公司此前与昭衍生物签署合资协议设立昭泰智药，打造mRNA药物研发与产业化平台。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，AI制药利好催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":-0.1819},{"period":"1month","weight":-0.135},{"period":"3month","weight":0.179},{"period":"6month","weight":0.1352},{"period":"ytd","weight":0.1352}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"剂泰科技（北京）股份有限公司是一家主要从事人工智能（AI）纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础，涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案，包括AiTEM、AiLNP及AiRNA平台，用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}